Thermo Electron Acquires Provider of Mass Spectrometry Ion Filtering Device
News Aug 12, 2005
Thermo Electron Corporation has announced that it has purchased Ionalytics Corporation, developer of a dynamic ion filtering device used with mass spectrometers in bioanalysis, proteomics and drug discovery.
Marijn E. Dekkers, president and chief executive officer of Thermo Electron said, "Ionalytics has made significant strides in advancing the core technologies used in drug discovery, most notably a novel ion separation tool based on patent-protected FAIMS (High-Field Asymmetric Waveform Ion Mobility Spectrometry) technology."
He adds, "We believe that the addition of FAIMS will contribute tremendously to our customer's ability to push their detection limits, which is critical to accelerate drug discovery research."
Further he said, "We will also continue to invest in several other promising initiatives currently underway at Ionalytics, as we build the most comprehensive mass spectrometry portfolio in the world."
According to Thermo, when combined with liquid chromatography mass spectrometry (LC-MS), FAIMS technology helps resolve analytical method development challenges.
Based on FAIMS technology, Ionalytics created the Selectra, an ion separation tool that reduces chemical background noise, increases throughput and improves detection limits.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE